IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (467)	3/10/1997 10:00:00 PM
From: Jerrold S Michaud	of 1762

Looks like everybody is planning where to put their profits from IDPH already. Congrats to everyone here! I noticed there are a lot of medical professionals here. Please check my web site, a FREE stock newsletter where I recommended IDPH at 21 7/8 back in January. I am currently excited about MEDI (Medimmune), a company that has a vaccine for RSV. The Phase III results to be reported in June (see todays pres release). They already have a similar product on the market (Respigam) that MDs out there may have become familiar with. I am a Clinical Lab Scientist and I saw Pediatricians jump for joy when this product became available. The product was so popular it had to be rationed since they could not manufacture enough to meet the demand. The new product (IMpact) currently in trial is monoclonal and can be administered IM which will lead to more widespread use. Please check the previous recommendations section (end of each page) under "stocks analysis" on my site for more detailed discussion. cwia.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next